天準科技(688003.SH):擬投建年產1000台/套基於機器視覺的智能檢測系統及產線新建項目
格隆匯 3 月 9日丨天準科技(688003.SH)公佈,為抓住我國產業結構轉型升級、製造業自動化及智能化進程加速發展的歷史機遇,進一步開拓機器視覺與智能製造領域的新業務,公司擬自籌資金投資建設“年產1000台/套基於機器視覺的智能檢測系統及產線新建項目”,主要用於半導體領域的智能檢測裝備、無人物流車和PCB領域裝備等產品的研發、測試、中試和生產等。
項目總投資額5億元,佔地39,880㎡,建築面積95,478㎡。項目投資建設主體為公司,預計建設期為48個月,項目建設地點位於蘇州高新區科技城。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.